Form 4 for ELV Elevance Health
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001156039-22-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-02 | ELV | Gallina John E | EVP, CFO | G - Gift | $0.00 | -1,420 | 56.2K | -2% | $0 |
| DM | 2022-03-03 | 2022-03-01 | ELV | Gallina John E | EVP, CFO | A - Grant | $0.00 | +11.2K | 58.0K | +24% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | Gallina John E | EVP, CFO | F - Tax | $452.58 | -4,575 | 46.9K | -9% | -$2.07M |
| D | 2022-03-03 | 2022-03-01 | ELV | Gallina John E | EVP, CFO | A - Grant | $0.00 | +11.6K | 11.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-02 | G | D | 1,420 | $0.00 | 56,181 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | A | A | 2,907 | $0.00 | 49,764 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 969 shares each on 3/1/2023, 3/1/2024 and 3/1/2025. |
| 3 | Common | Common Stock | 2022-03-01 | A | A | 8,250 | $0.00 | 58,014 | D | — | — | (F3) Represents performance based restricted share units. Restrictions lapse on 3/1/2022. |
| 4 | Common | Common Stock | 2022-03-02 | F | D | 413 | $463.49 | 57,601 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 5 | Common | Common Stock | 2022-03-01 | F | D | 4,162 | $451.50 | 46,857 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2022-03-01 | A | A | 11,594 | $0.00 | 11,594 | D | $451.50 · — to 2032-03-01 | 11,594 Common Stock | (F4) The option represents a right to purchase a total of 11,594 shares, and is exercisable in three annual installments, with one installment of 3,864 shares and two installments of 3,865 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date. |